Memorial Hospital Of Converse County

CLIA Laboratory Citation Details

4
Total Citations
50
Total Deficiencyies
20
Unique D-Tags
CMS Certification Number 53D0662194
Address 111 South 5th Street, Douglas, WY, 82633
City Douglas
State WY
Zip Code82633
Phone(307) 358-2122

Citation History (4 surveys)

Survey - May 12, 2022

Survey Type: Standard

Survey Event ID: 1OUM11

Deficiency Tags: D5209 D5403 D5407 D5445 D5445 D5449 D6168 D5209 D5403 D5407 D5449 D6168 D6171 D6171

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: . Based on review of personnel files, review of the CMS 209 Laboratory Personnel Report, lack of documentation, and staff interview, the technical supervisor failed to complete an initial competency assessment for 4 of 8 (TP #1, TP #4, TP #5, TP #6) new testing personnel prior to patient testing. In addition, an annual competency assessments had not been completed for 6 of 6 respiratory therapists (TP #7, TP #8, TP #9, TP #10, TP #11, TP #12) and the technical supervisor (TS) for 2 of 2 years reviewed (2020, 2021). The findings were: 1. Review of the personnel file for TP #1 showed she was hired in January of 2022. There was no evidence the technical supervisor had completed an initial competency assessment prior to TP #1 independently testing patient samples. Interview with the technical supervisor on 5/11 /22 at 10:30 AM revealed TP #1 worked the 3rd shift. 2. Review of the personnel file for TP #4 showed she was hired in April of 2022. There was no evidence the technical supervisor had completed an initial competency assessment prior to TP #4 independently testing patient samples. Interview with the technical supervisor on 5/11 /22 at 10:30 AM revealed TP #4 worked the 3rd shift. 3. Review of the personnel file for TP #5 and TP #6 showed no evidence the technical supervisor had completed an initial competency assessment prior to TP #5 and TP #6 independently testing patient samples. 4. Review of the personnel files for TP #7, TP #8, TP #9, TP #10, TP #11, and TP #12 showed no evidence an annual competency assessment was completed in 2020 or in 2021. 5. Review of the laboratory's records showed no evidence a competency assessment was completed for the TS in 2020 or in 2021. 5. Interview on 5/12/22 at 9:55 AM with the lead respiratory therapist revealed he was unable to Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 6 -- locate the competency assessments for the respiratory therapy staff that performed blood gas analyses. 6. Interview with the technical supervisor on 5/11/22 at 2:53 PM revealed the lead respiratory therapist was responsible for conducting the competency assessments for testing personnel in the respiratory therapy department. In an additional interview with the technical supervisor on 5/12/22 at 10:16 AM she confirmed the competency assessments had not been completed. . D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 4, 2020

Survey Type: Standard

Survey Event ID: WIRO11

Deficiency Tags: D5411 D5421 D6063 D6065 D6086 D6128 D5407 D5411 D5421 D6063 D6065 D6086 D6128

Summary:

Summary Statement of Deficiencies D5407 PROCEDURE MANUAL CFR(s): 493.1251(d) Procedures and changes in procedures must be approved, signed, and dated by the current laboratory director before use. This STANDARD is not met as evidenced by: Based on new instrument verification study review, lack of documentation, and interview with staff, the laboratory director failed to sign and date the procedure for EPOC blood gas analysis as approved. Findings include: 1. Verification studies reviewed included documentation he laboratory introduced a new EPOC test system for blood gas (venous and arterial) in June of 2020. 2. The laboratory used the EPOC operator's manual as the procedure. 3. The EPOC operator's manual failed to include the director's signature and date of approval. 4. In an interview conducted on 08/04 /2020 at approximately 2:15 P.M., the laboratory manager and lead technician in the blood gas lab confirmed the director had not approved the operator's manual. D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) Test systems must be selected by the laboratory. The testing must be performed following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. This STANDARD is not met as evidenced by: Based on patient test records review, quality control records review, and interview with staff, the laboratory failed to document they followed the BD Affirm VP manufacturer's instructions to record the temperature of the heat block and internal Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- controls to ensure the incubation was within the 85 degrees plus or minus 5 degrees range for 1 of 1 patient test reviewed collected on 11/14/2019. The laboratory performed approximately 10 to 15 tests per month. Findings include: 1. Patient test records review included Affirm VP test report for the presence or absence of Gardnerella, Trichomonas, and Candida for patient specimen 19:MC0006358R on 11 /14/2019. 2. Quality control records review and temperature documentation review failed to document the lab followed the BD Affirm VP instructions to evaluate the positive and negative internal controls and the temperature of the test heat block for each test performed. 3. In an interview conducted on 09/04/2020 at approximately 5: 00 P.M., the laboratory manager confirmed the laboratory failed to record the heat block temperature and internal positive and negative controls as instructed by the manufacturer. D5421 ESTABLISHMENT AND VERIFICATION OF PERFORMANCE CFR(s): 493.1253(b)(1) Each laboratory that introduces an unmodified, FDA-cleared or approved test system must do the following before reporting patient test results: (1)(i) Demonstrate that it can obtain performance specifications comparable to those established by the manufacturer for the following performance characteristics: (1)(i)(A) Accuracy. (1)(i) (B) Precision. (1)(i)(C) Reportable range of test results for the test system. (1)(ii) Verify that the manufacturer's reference intervals (normal values) are appropriate for the laboratory's patient population. This STANDARD is not met as evidenced by: Based on EPOC blood gas instrument verification records review, lack of documentation, and interview with staff, the laboratory failed to verify 3 of 3 measured tests reported, pH, Partial Pressure Carbon Dioxide, (pCO2), and partial pressure Oxygen (pO2) for accuracy and precision. The laboratory performed approximately 950 blood gas tests per year. Findings include: 1. EPOC blood gas instrument verification failed to include the statistical evaluation of accuracy and precision for pH, pCO2 and pO2 tests for determination of how close the detected results are to the expected results and the ability of the instrument to report the same value for the same specimen. The laboratory failed to document the reportable range results were linear. 2. In an interview conducted on 09/04/2020 at approximately 2:00 P.M., the laboratory manager and blood gas lead technician confirmed the laboratory had not completed the verification study to determine the accuracy and precision of the instrument and that the instrument reporting of values at low normal and high values were linear. D6063 LABORATORY TESTING PERSONNEL CFR(s): 493.1421 The laboratory must have a sufficient number of individuals who meet the qualification requirements of 493.1423, to perform the functions specified in 493. 1425 for the volume and complexity of tests performed. This CONDITION is not met as evidenced by: Based on personnel competency records review, lack of documentation, and interview with staff, 1 of 1 new testing person (P) failed to have the educational documentation to qualify as a moderate complexity testing person. (See D6065) -- 2 of 4 -- D6065 TESTING PERSONNEL QUALIFICATIONS CFR(s): 493.1423(b)(1)(2)(3)(4)(i) (b) Meet one of the following requirements: (b)(1) Be a doctor of medicine or doctor of osteopathy licensed to practice medicine or osteopathy in the State in which the laboratory is located or have earned a doctoral, master's, or bachelor's degree in a chemical, physical, biological or clinical laboratory science, or medical technology from an accredited institution; or (b)(2) Have earned an associate degree in a chemical, physical or biological science or medical laboratory technology from an accredited institution; or (b)(3) Be a high school graduate or equivalent and have successfully completed an official military medical laboratory procedures course of at least 50 weeks duration and have held the military enlisted occupational specialty of Medical Laboratory Specialist (Laboratory Technician); or (b)(4)(i) Have earned a high school diploma or equivalent; and This STANDARD is not met as evidenced by: Based on personnel qualification records review, lack of documentation, and confirmation by the laboratory manager, the laboratory failed to have documentation to qualify 1 of 1 new moderate complexity testing person (P). Findings include: 1. Personnel qualification records review failed to include educational documentation test person P qualified as a moderate complexity test person. 2. In an interview conducted on 09/04/2020 at approximately 6:45 P.M., the laboratory manager confirmed test person P did not have documentation to meet the educational benchmark to perform moderate complexity testing. D6086 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(3)(ii) The laboratory director must ensure that verification procedures used are adequate to determine the accuracy, precision, and other pertinent performance characteristics of the method. This STANDARD is not met as evidenced by: Based on EPOC blood gas instrument verification studies review, lack of documentation, and interview with staff, the laboratory director failed to approve the verification study for the instrument in use since 06/23/2020. The laboratory performed approximately 80 tests per month. Findings include: 1. The laboratory verified the EPOC instrument on 06/23/2020. 2. The laboratory verification studies failed to include the approval of the director ensuring the verification procedure was adequate to determine the accuracy, precision and reportable range and that the normal range was consistent with the previous test method or if normal ranges were to be adjusted due to method variation. D6128 TECHNICAL SUPERVISOR RESPONSIBILITIES CFR(s): 493.1451(b)(9) The technical supervisor is responsible for evaluating and documenting the performance of individuals responsible for high complexity testing at least annually after the first year, unless test methodology or instrumentation changes, in which case, prior to reporting patient test results, the individual's performance must be reevaluated to include the use of the new test methodology or instrumentation. -- 3 of 4 -- This STANDARD is not met as evidenced by: Based on competency records review, lack of documentation, and confirmation by staff, the technical supervisor failed to evaluate competency for 3 of 17 testing personnel for 1 of 2 years reviewed (September 2018 to September 2020). Findings include: 1. Competency records review failed to include competency evaluations for testing persons D, G, and P for 2019. 2. In an interview conducted on 09/03/2020 at approximately 7:00 P.M., the technical supervisor for Chemistry, General Immunology, Microbiology, and Hematology confirmed the 2019 competency evaluation was incomplete for test person D and not available for tests persons G and P. -- 4 of 4 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 10, 2019

Survey Type: Standard

Survey Event ID: 6ME913

Deficiency Tags: D5413 D5473 D6094 D5413 D5473 D6094

Summary:

Summary Statement of Deficiencies D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on lack of documentation, direct observation, procedure manual review, and interview with the laboratory supervisor, the laboratory failed to record the cryostat temperature for 1 day of frozen section testing performed on 12/27/2018 for two cases of frozen section testing for a total of 9 specimens processed. Findings include: 1. The laboratory failed to record the temperature of the cryostat documenting the instrument was operating at the selected temperature for the type of specimen being processed on 12/27/2018. 2. The Cryostat was observed to be operating at -31 degrees C on 04/10 /2019. The range of acceptable temperature stated in the laboratory procedure was -19 to -23 degrees C. 3. In an interview conducted 04/10/2019 at approximately 8:15 A. M., the laboratory supervisor confirmed the laboratory did not record the cryostat temperature each day of testing for one day testing was performed since opening. D5473 CONTROL PROCEDURES CFR(s): 493.1256(e)(2)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e) (2) Each day of use (unless otherwise specified in this subpart), test staining materials for intended reactivity to ensure predictable staining characteristics. Control materials Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- for both positive and negative reactivity must be included, as appropriate. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on patient test reports review, lack of documentation, and interview with the laboratory supervisor, the laboratory failed to check Hematoxylin and Eosin (H&E) stain each day of testing for intended reactivity and predictable staining characteristics for 1 of 1 testing day (December 27, 2018). Findings include: 1. Patient test reports reviewed include histopathology diagnoses read from H&E stained slides for histopathology cases 11846892 and 11847573. 2. In an interview conducted on 04/10 /2019 at approximately 8:35 A.M. the laboratory supervisor confirmed the laboratory did not record stain adequacy on 12/27/2018, the only day frozen section staining was performed. D6094 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality assessment programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: No deficiency details available. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 30, 2018

Survey Type: Standard

Survey Event ID: 6ME911

Deficiency Tags: D5293 D5407 D5411 D5439 D5445 D5449 D6063 D6111 D5439 D5445 D5449 D6063 D6065 D6108 D6111 D6065 D6108

Summary:

Summary Statement of Deficiencies D5293 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(b)(c) (b) The general laboratory systems quality assessment must include a review of the effectiveness of

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access